Mutation Variants and Co-Mutations as Genomic Modifiers of Response to Afatinib in HER2-Mutant Lung Adenocarcinoma.
Fang W, Zhao S, Liang Y, Yang Y, Yang L, Dong X, Zhang L, Tang Y, Wang S, Yang Y, Ma X, Wang M, Wang W, Zhao S, Wang K, Gao S, Zhang L.
Fang W, et al. Among authors: liang y.
Oncologist. 2020 Mar;25(3):e545-e554. doi: 10.1634/theoncologist.2019-0547. Epub 2019 Nov 20.
Oncologist. 2020.
PMID: 32162827
Free PMC article.